{"id":"https://openalex.org/W1596535979","doi":"https://doi.org/10.1111/j.1476-5381.2011.01718.x","title":"Development of a radioiodinated apoptosis\u2013inducing ligand, rhTRAIL, and a radiolabelled agonist TRAIL receptor antibody for clinical imaging studies","display_name":"Development of a radioiodinated apoptosis\u2013inducing ligand, rhTRAIL, and a radiolabelled agonist TRAIL receptor antibody for clinical imaging studies","publication_year":2011,"publication_date":"2011-10-21","ids":{"openalex":"https://openalex.org/W1596535979","doi":"https://doi.org/10.1111/j.1476-5381.2011.01718.x","mag":"1596535979","pmid":"https://pubmed.ncbi.nlm.nih.gov/22014269","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3413857"},"language":"en","primary_location":{"id":"doi:10.1111/j.1476-5381.2011.01718.x","doi":"https://doi.org/10.1111/j.1476-5381.2011.01718.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1476-5381.2011.01718.x","pdf_url":null,"source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3413857","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5049663351","display_name":"Evelien W. Duiker","orcid":"https://orcid.org/0000-0002-9450-5282","observed_orcids":["https://orcid.org/0000-0002-9450-5282"]},"institutions":[{"id":"https://openalex.org/I169381384","display_name":"University of Groningen","ror":"https://ror.org/012p63287","country_code":"NL","type":"education","lineage":["https://openalex.org/I169381384"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"EW Duiker","raw_affiliation_strings":["Department of Medical Oncology, University of Groningen, the Netherlands","Departments of Medical Oncology","These authors contributed equally to this work"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, University of Groningen, the Netherlands","institution_ids":["https://openalex.org/I169381384"]},{"raw_affiliation_string":"Departments of Medical Oncology","institution_ids":[]},{"raw_affiliation_string":"These authors contributed equally to this work","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025440216","display_name":"Eli C. F. Dijkers","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799567177","display_name":"Society of Nuclear Medicine and Molecular Imaging","ror":"https://ror.org/02k5gcb44","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I2799567177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"ECF Dijkers","raw_affiliation_strings":["Hospital and Clinical Pharmacy","Nuclear Medicine and Molecular Imaging","These authors contributed equally to this work"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital and Clinical Pharmacy","institution_ids":[]},{"raw_affiliation_string":"Nuclear Medicine and Molecular Imaging","institution_ids":["https://openalex.org/I2799567177"]},{"raw_affiliation_string":"These authors contributed equally to this work","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031624913","display_name":"Hiddo J.L. Heerspink","orcid":"https://orcid.org/0000-0002-3126-3730","observed_orcids":["https://orcid.org/0000-0002-3126-3730"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H Lambers Heerspink","raw_affiliation_strings":["Hospital and Clinical Pharmacy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital and Clinical Pharmacy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051509827","display_name":"Steven de Jong","orcid":"https://orcid.org/0000-0001-5831-6997","observed_orcids":["https://orcid.org/0000-0001-5831-6997"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S de Jong","raw_affiliation_strings":["Departments of Medical Oncology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Medical Oncology","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110460744","display_name":"Agj van der Zee","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334415907","display_name":"University Medical Center Groningen","ror":"https://ror.org/03cv38k47","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I1334415907"]},{"id":"https://openalex.org/I169381384","display_name":"University of Groningen","ror":"https://ror.org/012p63287","country_code":"NL","type":"education","lineage":["https://openalex.org/I169381384"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"AGJ van der Zee","raw_affiliation_strings":["Gynaecological Oncology, University Medical Center Groningen, University of Groningen, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gynaecological Oncology, University Medical Center Groningen, University of Groningen, the Netherlands","institution_ids":["https://openalex.org/I1334415907","https://openalex.org/I169381384"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108091121","display_name":"P.L. Jager","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799567177","display_name":"Society of Nuclear Medicine and Molecular Imaging","ror":"https://ror.org/02k5gcb44","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I2799567177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"PL Jager","raw_affiliation_strings":["Nuclear Medicine and Molecular Imaging"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nuclear Medicine and Molecular Imaging","institution_ids":["https://openalex.org/I2799567177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060465721","display_name":"Jos G. W. Kosterink","orcid":"https://orcid.org/0000-0001-8358-765X","observed_orcids":["https://orcid.org/0000-0001-8358-765X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"JGW Kosterink","raw_affiliation_strings":["Hospital and Clinical Pharmacy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital and Clinical Pharmacy","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"EGE de Vries","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"EGE de Vries","raw_affiliation_strings":["Departments of Medical Oncology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Medical Oncology","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112284530","display_name":"Marjolijn N. Lub\u2013de Hooge","orcid":"https://orcid.org/0000-0002-5390-2791","observed_orcids":["https://orcid.org/0000-0002-5390-2791"]},"institutions":[{"id":"https://openalex.org/I2799567177","display_name":"Society of Nuclear Medicine and Molecular Imaging","ror":"https://ror.org/02k5gcb44","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I2799567177"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"MN Lub\u2010de Hooge","raw_affiliation_strings":["Hospital and Clinical Pharmacy","Nuclear Medicine and Molecular Imaging"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital and Clinical Pharmacy","institution_ids":[]},{"raw_affiliation_string":"Nuclear Medicine and Molecular Imaging","institution_ids":["https://openalex.org/I2799567177"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5112284530"],"corresponding_institution_ids":["https://openalex.org/I2799567177"],"apc_list":{"value":4780,"currency":"USD","value_usd":4780},"apc_paid":null,"fwci":1.5011,"has_fulltext":false,"cited_by_count":20,"citation_normalized_percentile":{"value":0.78976147,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"165","issue":"7","first_page":"2203","last_page":"2212"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10522","display_name":"Medical Imaging Techniques and Applications","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/trail","display_name":"TRAIL","score":0.8809999823570251},{"id":"https://openalex.org/keywords/trail-receptor-1","display_name":"TRAIL receptor 1","score":0.7689999938011169},{"id":"https://openalex.org/keywords/mapatumumab","display_name":"mapatumumab","score":0.9309999942779541},{"id":"https://openalex.org/keywords/radioiodination","display_name":"radioiodination","score":0.847000002861023},{"id":"https://openalex.org/keywords/111in","display_name":"indium-111","score":0.8769999742507935},{"id":"https://openalex.org/keywords/radiopharmaceuticals","display_name":"radiopharmaceuticals","score":0.8550000190734863},{"id":"https://openalex.org/keywords/radioimmunoconjugates","display_name":"radioimmunoconjugates","score":0.8510000109672546},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.41100001335144043},{"id":"https://openalex.org/keywords/death-receptors","display_name":"death receptors","score":0.6480000019073486},{"id":"https://openalex.org/keywords/tissue-distribution","display_name":"tissue distribution","score":0.8519999980926514},{"id":"https://openalex.org/keywords/tumor-xenografts","display_name":"tumor xenografts","score":0.9449999928474426},{"id":"https://openalex.org/keywords/renal-clearance","display_name":"renal clearance","score":0.5730000138282776},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.6669999957084656},{"id":"https://openalex.org/keywords/tumor-targeting","display_name":"tumor targeting","score":0.5619999766349792}],"concepts":[{"id":"https://openalex.org/C2777807558","wikidata":"https://www.wikidata.org/wiki/Q4914764","display_name":"Biodistribution","level":3,"score":0.9293668270111084},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.676414966583252},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5654890537261963},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.5648707747459412},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5513800382614136},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.5058996081352234},{"id":"https://openalex.org/C116569031","wikidata":"https://www.wikidata.org/wiki/Q899107","display_name":"Ligand (biochemistry)","level":3,"score":0.5053725838661194},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.47053417563438416},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.46214067935943604},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.4494841992855072},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.36917558312416077},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3624265193939209},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3342271149158478},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.33015918731689453},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.22181373834609985},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.16446810960769653},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007205","descriptor_name":"Indium Radioisotopes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007457","descriptor_name":"Iodine Radioisotopes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007553","descriptor_name":"Isotope Labeling","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008819","descriptor_name":"Mice, Nude","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D014018","descriptor_name":"Tissue Distribution","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019275","descriptor_name":"Radiopharmaceuticals","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D019275","descriptor_name":"Radiopharmaceuticals","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053220","descriptor_name":"Receptors, TNF-Related Apoptosis-Inducing Ligand","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D053220","descriptor_name":"Receptors, TNF-Related Apoptosis-Inducing Ligand","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D053220","descriptor_name":"Receptors, TNF-Related Apoptosis-Inducing Ligand","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":true},{"descriptor_ui":"D053221","descriptor_name":"TNF-Related Apoptosis-Inducing Ligand","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D053221","descriptor_name":"TNF-Related Apoptosis-Inducing Ligand","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D053221","descriptor_name":"TNF-Related Apoptosis-Inducing Ligand","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":6,"locations":[{"id":"doi:10.1111/j.1476-5381.2011.01718.x","doi":"https://doi.org/10.1111/j.1476-5381.2011.01718.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1476-5381.2011.01718.x","pdf_url":null,"source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:3481677","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3413857","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3413857","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3413857","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Pharmacol","raw_type":"Text"},{"id":"pmid:22014269","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22014269","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of pharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:pure.rug.nl:openaire_cris_publications/11e0517d-638f-4801-b113-08e473b575a7","doi":null,"is_oa":false,"landing_page_url":"https://research.rug.nl/en/publications/11e0517d-638f-4801-b113-08e473b575a7","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Duiker, E W, Dijkers, E C F, Heerspink, H L, de Jong, S, van der Zee, A G J, Jager, P L, Kosterink, J G W, de Vries, E G E & Lub-de Hooge, M N 2012, 'Development of a radioiodinated apoptosis-inducing ligand, rhTRAIL, and a radiolabelled agonist TRAIL receptor antibody for clinical imaging studies', British Journal of Pharmacology, vol. 165, no. 7, pp. 2203-2212. https://doi.org/10.1111/j.1476-5381.2011.01718.x","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:rug:oai:pure.rug.nl:publications/11e0517d-638f-4801-b113-08e473b575a7","doi":null,"is_oa":false,"landing_page_url":"https://research.rug.nl/en/publications/11e0517d-638f-4801-b113-08e473b575a7","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"British Journal of Pharmacology, 165(7), 2203 - 2212. Wiley-Blackwell","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"pmh:oai:europepmc.org:3481677","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3413857","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},"sustainable_development_goals":[{"score":0.8999999761581421,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320322777","display_name":"KWF Kankerbestrijding","ror":"https://ror.org/0368jnd28"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":36,"referenced_works":["https://openalex.org/W188996788","https://openalex.org/W208571004","https://openalex.org/W1496036360","https://openalex.org/W1910698471","https://openalex.org/W1967928952","https://openalex.org/W1974144614","https://openalex.org/W1977424447","https://openalex.org/W1982322665","https://openalex.org/W1988180315","https://openalex.org/W2039751522","https://openalex.org/W2047390867","https://openalex.org/W2058426435","https://openalex.org/W2066863872","https://openalex.org/W2074152898","https://openalex.org/W2086207288","https://openalex.org/W2088291142","https://openalex.org/W2091574965","https://openalex.org/W2096141271","https://openalex.org/W2099516468","https://openalex.org/W2102629299","https://openalex.org/W2106284224","https://openalex.org/W2109587559","https://openalex.org/W2115978863","https://openalex.org/W2120529769","https://openalex.org/W2130870133","https://openalex.org/W2130988210","https://openalex.org/W2150384126","https://openalex.org/W2159153230","https://openalex.org/W2159999972","https://openalex.org/W2168198903","https://openalex.org/W2169344120","https://openalex.org/W2171865821","https://openalex.org/W2185804080","https://openalex.org/W2340273273","https://openalex.org/W2917216229","https://openalex.org/W3012002131"],"related_works":["https://openalex.org/W2242567721","https://openalex.org/W4411055838","https://openalex.org/W7095320205","https://openalex.org/W2991375917","https://openalex.org/W2169344120","https://openalex.org/W2337789734","https://openalex.org/W1178456923","https://openalex.org/W2124673635","https://openalex.org/W4389475052","https://openalex.org/W2008784330"],"abstract_inverted_index":{"BACKGROUND":[0],"AND":[1,186],"PURPOSE:":[2],"The":[3,38,79,195],"TNF-related":[4],"apoptosis":[5,10],"inducing":[6],"ligand":[7],"(TRAIL)":[8],"induces":[9],"through":[11],"activation":[12],"of":[13,40,110,134,213],"the":[14,25,48,125,161,180,214],"death":[15,88],"receptors,":[16],"TRAIL-R1":[17,26],"and":[18,24,57,71,87,94,119,144,170,173,189,206],"TRAIL-R2.":[19],"Recombinant":[20],"human":[21,104],"(rh)":[22],"TRAIL":[23],"directed":[27],"monoclonal":[28],"antibody":[29],"mapatumumab":[30,73,164,190],"are":[31],"currently":[32],"clinically":[33,201],"evaluated":[34],"as":[35],"anticancer":[36],"agents.":[37],"objective":[39],"this":[41],"study":[42,203],"was":[43,66,74,98],"to":[44,54,202],"develop":[45],"radiopharmaceuticals":[46,80,197],"targeting":[47,90],"TRAIL-R1,":[49],"suitable":[50],"for":[51,124,160],"clinical":[52,59],"use":[53],"help":[55],"understand":[56],"predict":[58],"efficacy":[60],"in":[61,84,95,100,155,177,179,218],"patients.":[62],"EXPERIMENTAL":[63],"APPROACH:":[64],"rhTRAIL":[65,188],"radioiodinated":[67],"with":[68,76,107,137],"(125)":[69],"I,":[70],"conjugated":[72],"radiolabelled":[75],"(111)":[77],"In.":[78],"were":[81,92,122],"characterized,":[82],"their":[83],"vitro":[85],"stability":[86,118],"receptor":[89,182],"capacities":[91],"determined":[93],"vivo":[96,128],"biodistribution":[97,129,205],"studied":[99],"nude":[101],"mice":[102],"bearing":[103],"tumour":[105,207],"xenografts":[106],"different":[108],"expression":[109,183],"TRAIL-R1.":[111],"KEY":[112],"RESULTS:":[113],"Labelling":[114],"efficiencies,":[115],"radiochemical":[116],"purity,":[117],"binding":[120],"properties":[121],"optimized":[123],"radioimmunoconjugates.":[126],"In":[127],"showed":[130,165],"rapid":[131],"renal":[132],"clearance":[133,167],"[(125)":[135],"I]rhTRAIL,":[136],"highest":[138],"kidney":[139],"activity":[140,148],"at":[141],"15":[142],"min":[143],"almost":[145,156],"no":[146],"detectable":[147],"after":[149],"4":[150],"h.":[151],"Activity":[152],"rapidly":[153],"decreased":[154],"all":[157],"organs,":[158],"except":[159],"xenografts.":[162],"Radiolabelled":[163],"blood":[166],"between":[168],"24":[169],"168":[171],"h":[172],"a":[174],"reduced":[175],"decrease":[176],"radioactivity":[178],"high":[181],"xenograft.":[184],"CONCLUSIONS":[185],"IMPLICATIONS:":[187],"can":[191,198],"be":[192,199],"efficiently":[193],"radiolabelled.":[194],"new":[196],"used":[200],"pharmacokinetics,":[204],"targeting,":[208],"which":[209],"could":[210],"support":[211],"evaluation":[212],"native":[215],"targeted":[216],"agents":[217],"phase":[219],"I/II":[220],"trials.":[221]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}